Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 8 months
- Director since
- 2026
8 months of board service in total across 1 board, counting each seat separately. Longest: Aktis Oncology Inc., 8 months.
Aktis Oncology Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 20, 2026 | Aktis Oncology Inc. | Option exercise | +3,506 | $0.08 | $280 |
| Jul 20, 2026 | Aktis Oncology Inc. | Option exercise | +1,350 | $1.91 | $2,579 |
| Jul 20, 2026 | Aktis Oncology Inc. | Open-market sale | −3,506 | $24.56 | $86,115 |
| Jul 20, 2026 | Aktis Oncology Inc. | Open-market sale | −1,350 | $24.56 | $33,159 |
| Jul 17, 2026 | Aktis Oncology Inc. | Option exercise | +3,065 | $0.08 | $245 |
| Jul 17, 2026 | Aktis Oncology Inc. | Open-market sale | −3,065 | $25.21 | $77,259 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.